Clinical trial
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
NCT00148993 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00148993 |
|---|---|
| Title | Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors |
| Official title | Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | The International Center for Cell Therapy & Cancer Immunotherapy (CTCI) |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Solid Tumors |
| Intervention type | Biological |
| Interventions | Tumor Cell Vaccine |
| Enrollment | 100 |
| Start date | Jul 1, 1998 |
| Completion | Jul 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 8, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: